Topic Lifecycle: Dormant
This topic is currently dormant in the news cycle. It was last covered on Friday 23 October 2026 and has not appeared in recent broadcasts.
Coverage trend (last 30 days)
How much coverage this topic got from each channel over the past month.
On screen
Stills are sampled automatically at 60-second intervals. Where shown, the still is the nearest available frame from the relevant broadcast segment and is included to show what was on screen during that part of the broadcast. A still may not correspond to the exact second of a quoted phrase.
Recent stories
The latest story timelines linked to this topic, newest activity first.
What was reported
A plain summary of this topic, built from the channels that covered it.
BBC News, ITV1 and 5 reported that MPs said the NHS rollout of the weight loss drug Mounjaro in England was too limited and that more people should be offered it. BBC News and 5 identified the Commons Health and Social Care Committee, with 5 describing it as a cross-party group of MPs. 5 reported that the plan to provide the drug free to around 220,000 people by 2028 covered only about 6% of eligible people and was too small. BBC News and ITV1 reported that the rollout was expected to reach around 220,000 people in England over three years, about 6% of eligible patients. BBC News said NHS England estimated around 2.8 million patients in England would be eligible and that treating all of them at once would cost about £15 billion over five years. ITV1 reported that the report warned of a postcode lottery in access and quoted a doctor saying the NHS could not currently cope with everyone who needed the drugs. BBC News said access to Mounjaro on the NHS was also tightly restricted in the rest of the UK, that a recent BBC investigation in Scotland found fewer than 800 people had received weight loss jabs in the three years since they were approved, and that private prescriptions had soared. 5 reported that MPs warned only people who could afford to pay privately were getting access. NHS England said it was prioritising the most severe and complex cases and that more patients would get access as capacity and funding allowed, with ITV1 reporting it was determined to expand access.
Key Claims by Channel
Monday 6 July 2026
| Claim |  |  |  |
|---|---|---|---|
| Reported by all 3 channels | |||
| Wegovi weight-loss drug became available in pill form in the UK on 6 July 2026. | Reported by Channel 5 | Reported by BBC One | Reported by ITV |
| The pill is available only via private prescription, not on the NHS. | Reported by BBC One | Reported by ITV | |
| Reported by a few · 2 channels | |||
| The pill is approved for people with a BMI of 30 or higher, or a BMI of at least 27 with a weight-related condition. | Not reported by Channel 5 | Reported by ITV | |
| The pill costs about the same as the injectable version. | Not reported by Channel 5 | Reported by BBC One | Reported by ITV |
| Only on one channel | |||
| The pill does not require refrigeration, unlike the injections. | Not reported by Channel 5 | Reported by BBC One | Not reported by ITV |
| Side effects include headaches, nausea, diarrhoea, constipation, and more serious risks such as eye problems and pancreatitis. | Not reported by Channel 5 | Not reported by ITV | |
| Novo Nordisk's CEO said producing the pill is not cheaper than producing the injections. | Not reported by Channel 5 | Not reported by BBC One | |
| Novo Nordisk is partnering with authorities and law enforcement to prevent counterfeiting of the pills. | Not reported by Channel 5 | Not reported by BBC One | |
| The pills could increase the risk of misuse by people with eating disorders or for cosmetic reasons; Novo Nordisk emphasised education to address this. | Not reported by Channel 5 | Not reported by BBC One | Reported by ITV |
| An expert commented that more must be done to change the food environment to prevent obesity. | Not reported by Channel 5 | Reported by BBC One | Not reported by ITV |
| The medicines regulator has approved the pill form. | Reported by Channel 5 | Not reported by BBC One | Not reported by ITV |
| Counterfeit versions are a concern because pills are easier to fake than injections. | Reported by Channel 5 | Not reported by BBC One | Not reported by ITV |
Monday 24 August 2026
| Claim | | |  | |
|---|---|---|---|---|
| Widely reported · 3 or more of 4 channels | ||||
| The drug is a daily pill also designed to treat diabetes. | Reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | |
| Reported by a few · 2 channels | ||||
| Fandeo is the UK's first once-daily weight loss pill, approved two weeks ago and currently only available privately. | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV | |
| The drug could become available on the NHS. | Reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV |
| The drug will be on sale in pharmacies and online from Monday. | Not reported by BBC One | Not reported by ITV | ||
| The oral form makes treatment easier for people who cannot tolerate injections. | Reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV |
| Only on one channel | ||||
| The pill leads to an average weight loss of 11% over 22 weeks. | Reported by Channel 5 | Not reported by BBC One | Not reported by Channel 4 | Not reported by ITV |
| The pill is available to people with a BMI of 30, or 27 with a comorbidity such as diabetes. | Not reported by Channel 5 | Not reported by BBC One | Not reported by Channel 4 | |
| Men are more reluctant than women to disclose using weight loss drugs. | Not reported by Channel 5 | Reported by BBC One | Not reported by Channel 4 | Not reported by ITV |
| Fandeo works by blocking the GLP-1 receptor, slowing gastric emptying and reducing hunger. | Not reported by BBC One | Not reported by Channel 4 | Not reported by ITV | |
| Fandeo is licensed for obesity and related diseases, not for cosmetic weight loss. | Not reported by BBC One | Not reported by Channel 4 | Not reported by ITV | |
| The drug is described as a second weight loss pill of its kind. | Not reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV |
| Side effects include gastrointestinal issues such as stomach aches, diarrhea, and vomiting. | Reported by Channel 5 | Not reported by BBC One | Not reported by Channel 4 | Not reported by ITV |
| Long-term effects on the general population are not fully known. | Reported by Channel 5 | Not reported by BBC One | Not reported by Channel 4 | Not reported by ITV |
| The drug is made by Eli Lilly. | Not reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV |
| There are warnings about lack of rigor in obtaining the drug without an in-person consultation. | Not reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV |
| A researcher reported that 30% of surveyed individuals indicated low levels of rigor in pre-assessment checks. | Not reported by Channel 5 | Not reported by BBC One | Not reported by ITV | |
| The starting cost is around 100 pounds and increases over time. | Not reported by Channel 5 | Not reported by BBC One | Not reported by ITV | |
| A patient expressed concern about creating a two-tier health system where only those who can afford it get access. | Not reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV |
| The drug is a prescription-only medicine for a chronic condition, not a quick fix. | Not reported by Channel 5 | Not reported by BBC One | Reported by Channel 4 | Not reported by ITV |
| A man using Fandeo lost eight stone. | Not reported by Channel 5 | Reported by BBC One | Not reported by Channel 4 | Not reported by ITV |
| Fandeo should only be obtained on prescription. | Not reported by Channel 5 | Not reported by BBC One | Not reported by Channel 4 | |
Friday 23 October 2026
| Claim | |  | | |
|---|---|---|---|---|
| Widely reported · 3 or more of 4 channels | ||||
| MPs said NHS England was prescribing Mounjaro to very few eligible patients. | Reported by BBC News | |||
| MPs and the report warned of a postcode lottery in access to weight loss drugs, with only people able to afford private treatment getting access, and private prescriptions had soared. | Reported by BBC News | Not reported by BBC One | Reported by ITV | |
| Reported by a few · 2 channels | ||||
| NHS England said it was prioritising the most severe and complex cases, was determined to expand access, and would do so when capacity and funding allowed. | Not reported by Channel 5 | Reported by BBC News | Not reported by BBC One | Reported by ITV |
| Only on one channel | ||||
| NHS England estimated about 2.8 million patients in England would be eligible for Mounjaro. | Not reported by Channel 5 | Reported by BBC News | Not reported by BBC One | Not reported by ITV |
| Mounjaro was estimated to have been rolled out to about 220,000 people in England over three years, around 6% of eligible patients. | Not reported by Channel 5 | Reported by BBC News | Not reported by BBC One | Not reported by ITV |
| If all eligible patients came forward at once, Mounjaro would cost the NHS around £15 billion over five years. | Not reported by Channel 5 | Reported by BBC News | Not reported by BBC One | Not reported by ITV |
| Access to Mounjaro on the NHS was tightly restricted in the rest of the UK as well as in England. | Not reported by Channel 5 | Reported by BBC News | Not reported by BBC One | Not reported by ITV |
| A BBC investigation in Scotland found fewer than 800 people had received weight loss jabs in the three years since they were approved. | Not reported by Channel 5 | Reported by BBC News | Not reported by BBC One | Not reported by ITV |
| A clinician said the NHS could not currently cope with all the people who needed weight loss drugs, with patients asking daily but unable to be prescribed them. | Not reported by Channel 5 | Not reported by BBC News | Not reported by BBC One | |
| A patient, Emily Murray, lost 13 stone using privately paid weight loss medication after not meeting NHS criteria. | Not reported by Channel 5 | Not reported by BBC News | Not reported by BBC One | |
| A patient in Scotland, Kathleen, lost four stone on a pilot providing weight loss jabs, which she said improved her mobility and helped prepare for an operation. | Not reported by Channel 5 | Reported by BBC News | Not reported by BBC One | Not reported by ITV |
| A commentator said the NHS lacks the staff, funding and time needed to support patients using weight-loss medications. | Not reported by Channel 5 | Not reported by BBC News | Not reported by ITV | |
This is a cross-channel consensus summary, not an objective account. Consensus can be uniformly wrong, or omit what only one channel covered.
Flagged quotes
Disputed or loaded quotes across this topic's coverage, newest first.
Verbatim quotes flagged as contested or rhetorically charged. Presence here reflects language used, not a judgement of accuracy.
- contested
The government needs to be so much more ambitious about its rollout of GLP-1s, as well as developing a pathway where, well, if that doesn't work, and by the way, it doesn't work for everybody, …
- contested
Well, next tonight MPs are concerned that a two-tier system is emerging for the weight loss drug Mounjaro.
- contested
But they've never even tried, as far as we've seen.
- contested
It's all very well for the government to criticise the NHS but the NHS is so cash strapped and really struggling and you think about it now, how long does it take you to get in to see your GP?
- contested
NHS England says it's prioritising treatments for the most severe and complex cases but more patients will get access to the drugs when capacity and funding allows.
- charged
The health committee says the plan to give it for free to 220,000 people by 2028 is too small and covers only around 6% of those eligible.
- charged
MPs warn that only people who can afford to pay privately are getting access.
- charged
The report also points to a postcode lottery that fails those who need help most, arguing it comes down to luck, or in Emily's case, paying up for a healthier future.
- charged
And it shouldn't be a lottery of, oh, you can only afford it if you're well off.
- charged
MPs are accusing NHS England of prescribing the weight loss drug Mounjaro to a woefully small number of people.
Timeline
Where this topic appeared. Cells show coverage time and are darker when there was more coverage.
| Date | Channel 5 | BBC News | BBC One | BBC Two | Channel 4 | GB News | ITV | Sky News |
|---|---|---|---|---|---|---|---|---|
| Friday 23 October 2026 | 3m 6s 8.8% | 2m 31s 2.8% | 2m 25s 2.4% | — | — | — | 1m 49s 2.2% | — |
| Thursday 8 October 2026 | — | — | — | — | — | — | 5m 56s 7.0% | — |
| Friday 4 September 2026 | — | — | — | — | — | 8m 25s 12.4% | — | — |
| Monday 24 August 2026 | 2m 25s 6.9% | — | — | — | 4m 35s 8.7% | — | — | — |
| Thursday 20 August 2026 | — | — | 2m 24s 2.5% | — | — | — | — | — |
| Thursday 23 July 2026 | — | — | — | — | — | — | 2m 18s 3.4% | — |
| Monday 6 July 2026 | 6m 15s 14.8% | — | 2m 38s 4.6% | — | — | — | 6m 2s 9.6% | — |
| Wednesday 1 July 2026 | 2m 26s 6.6% | — | — | — | — | — | — | — |